Unique expression of HRF20 (CD59) in human nervous tissue

被引:11
作者
Akatsu, H
Yamada, T
Okada, N
Yamamoto, T
Yamashina, M
Okada, H
机构
[1] NAGOYA CITY UNIV,SCH MED,DEPT MOL BIOL,MIZUHO KU,NAGOYA,AICHI 467,JAPAN
[2] FUKUSHIMURA HOSP,CHOJU MED INST,TOYOHASHI,AICHI 441,JAPAN
[3] CHIBA UNIV,SCH MED,DEPT NEUROL,CHIBA 260,JAPAN
关键词
HRF20(CD59); DAF(CD55); MCP(CD46); CNS;
D O I
10.1111/j.1348-0421.1997.tb01208.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Damage to autologous tissue by complement is limited by several widely distributed membrane-associated glycoproteins which restrict the action of the complement in homologous species. These include decay accelerating factor (DAF), membrane cofactor protein (MCP) and 20 kDa homologous restriction factor (HRF20,CD59). Using immunohistochemical techniques, we examined the localization of these proteins in the central nervous system (CNS) and peripheral nervous system (PNS) using non-neurological human nervous tissue since some complement components have been demonstrated to be synthesized in the CNS. There was no evidence of parenchymal staining by anti-DAF or anti-MCP antibodies in either type of tissue except for the staining of the endothelium in capillaries. On the other hand, anti-HRF20 antibody clearly stained myelinated axons in the CNS as well as Schwann cells in the PNS. In addition, we detected positive staining by anti-DAF antibody in the PNS of a Paroxysmal nocturnal hemoglobinuria (PNH) patient who is genetically deficient in HRF20.
引用
收藏
页码:321 / 329
页数:9
相关论文
共 42 条
[31]  
TAKAHASHI M, 1995, P COMPLEMENT S, V32, P65
[32]  
TAKAIZAWA H, 1994, J IMMUNOL, V152, P3032
[33]   COMPLEMENT ACTIVATION BY ISOLATED MYELIN - ACTIVATION OF THE CLASSICAL PATHWAY IN THE ABSENCE OF MYELIN-SPECIFIC ANTIBODIES [J].
VANGURI, P ;
KOSKI, CL ;
SILVERMAN, B ;
SHIN, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (10) :3290-3294
[34]  
VEDELER C, 1994, IMMUNOLOGY, V82, P542
[35]   COMPLEMENT C1 INHIBITOR IS PRODUCED BY BRAIN-TISSUE AND IS CLEAVED IN ALZHEIMER-DISEASE [J].
WALKER, DG ;
YASUHARA, O ;
PATSTON, PA ;
MCGEER, EG ;
MCGEER, PL .
BRAIN RESEARCH, 1995, 675 (1-2) :75-82
[36]   COMPLEMENT AND CYTOKINE GENE-EXPRESSION IN CULTURED MICROGLIA DERIVED FROM POSTMORTEM HUMAN BRAINS [J].
WALKER, DG ;
KIM, SU ;
MCGEER, PL .
JOURNAL OF NEUROSCIENCE RESEARCH, 1995, 40 (04) :478-493
[37]   COMPLEMENT GENE-EXPRESSION IN NEUROBLASTOMA AND ASTROCYTOMA CELL-LINES OF HUMAN-ORIGIN [J].
WALKER, DG ;
MCGEER, PL .
NEUROSCIENCE LETTERS, 1993, 157 (01) :99-102
[38]   COMPLEMENT-ACTIVATED OLIGODENDROGLIA - A NEW PATHOGENIC ENTITY IDENTIFIED BY IMMUNOSTAINING WITH ANTIBODIES TO HUMAN-COMPLEMENT PROTEINS C3D AND C4D [J].
YAMADA, T ;
AKIYAMA, H ;
MCGEER, PL .
NEUROSCIENCE LETTERS, 1990, 112 (2-3) :161-166
[39]   INHERITED COMPLETE DEFICIENCY OF 20-KILODALTON HOMOLOGOUS RESTRICTION FACTOR-(CD59) AS A CAUSE OF PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA [J].
YAMASHINA, M ;
UEDA, E ;
KINOSHITA, T ;
TAKAMI, T ;
OJIMA, A ;
ONO, H ;
TANAKA, H ;
KONDO, N ;
ORII, T ;
OKADA, N ;
OKADA, H ;
INOUE, K ;
KITANI, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (17) :1184-1189
[40]  
YANG CY, 1993, J NEUROIMMUNOL, V47, P123